TELA Bio, Inc. Stock Issued
TELA Bio, Inc. (TELA) reported Stock Issued of $1.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2024-03-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:StockIssued1 · last filed 2024-03-22
- TELA Bio, Inc. stock issued for the quarter ending 2020-12-31 was $1.00K, a 0.00% change year-over-year.
- TELA Bio, Inc. stock issued for the quarter ending 2020-09-30 was $0.00.
- TELA Bio, Inc. stock issued for the quarter ending 2020-06-30 was $1.00K.
- TELA Bio, Inc. stock issued for the quarter ending 2020-03-31 was $1.00K.
- TELA Bio, Inc. stock issued for fiscal 2021 was $1.00K, a 66.67% decline from fiscal 2020.
- TELA Bio, Inc. stock issued for fiscal 2020 was $3.00K, a 25.00% decline from fiscal 2019.
- TELA Bio, Inc. stock issued for fiscal 2019 was $4.00K, a 20.00% decline from fiscal 2018.
- TELA Bio, Inc. stock issued for fiscal 2018 was $5.00K, a 83.87% decline from fiscal 2017.
| Period end | Stock Issued 3 month | Stock Issued 6 month | Stock Issued 9 month | Stock Issued 12 month |
|---|---|---|---|---|
| 2021-12-31 | $1.00K 10-K · filed 2024-03-22 | |||
| 2020-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.00K derived: sum of 2 quarters · filed 2023-03-23 | $2.00K derived: sum of 3 quarters · filed 2023-03-23 | $3.00K 10-K · filed 2023-03-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.00K derived: sum of 2 quarters · filed 2021-11-12 | $2.00K 10-Q · filed 2021-11-12 | $3.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.00K 10-Q · filed 2021-08-12 | $3.00K derived: sum of 3 quarters · filed 2022-03-23 | $3.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-14 | $2.00K derived: sum of 2 quarters · filed 2022-03-23 | $2.00K derived: sum of 3 quarters · filed 2022-03-23 | |
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $1.00K derived: sum of 2 quarters · filed 2022-03-23 | $4.00K 10-K · filed 2022-03-23 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $3.00K 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | $3.00K 10-Q · filed 2020-08-13 | |||
| 2018-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $5.00K 10-K · filed 2021-03-25 | ||
| 2018-09-30 | $3.00K 10-Q · filed 2019-12-18 | |||
| 2017-12-31 | $31.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |